ACO2 and epilepsy: In this study, we identified compound heterozygous mutations in ACO2 (p.[Asp512Asn; Gly666Ala]) in a patient with progressive cerebellar and cerebral atrophy, hypotonia, ataxia, seizure disorder, developmental delay, ophthalmological abnormalities and hearing loss.